Form 4: Hims & Hers Executive Executes Planned Stock Sale

Hims & Hers Health, Inc. PAO Irene Becklund reported the vesting of restricted stock units and subsequent sale of shares under a Rule 10b5-1 plan.

Summary

• Irene Becklund, Principal Accounting Officer (PAO) of Hims & Hers Health, Inc., acquired 15,971 shares of Class A Common Stock through the vesting of restricted stock units (RSUs).
• The company withheld 5,870 shares to cover tax obligations at a price of $30.17 per share.
• The reporting person sold 12,063 shares in total across two transactions on June 16 and June 17, 2026, at prices ranging from $30.25 to $31.50.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were executed under a pre-existing 10b5-1 plan and represent routine equity compensation management.

Positives

• The executive maintains a remaining beneficial ownership of 6,790 shares of Class A Common Stock following the reported transactions.
• The sales were conducted under a pre-established Rule 10b5-1 trading plan, which typically indicates scheduled liquidity rather than reactive selling based on non-public information.

Negatives

• The transaction represents a reduction in the executive's direct equity stake in the company.

Risks

• Future share price volatility may impact the value of remaining unvested restricted stock units held by the executive.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of individual insider transactions.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and tax obligations, and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is consistent with best practices for corporate officers in the healthcare and technology sectors to avoid allegations of insider trading.
• The scale of the sale is proportional to typical executive compensation vesting schedules observed in mid-cap growth companies.

Stakeholder Impact

• Minimal impact on shareholders as the transactions were pre-planned and represent a small portion of the executive's total potential equity.

Next Steps

• Continued vesting of remaining restricted stock units according to the established 4-year service-based schedule.

Key Dates

Keywords

Hims & Hers, HIMS, Insider Trading, Form 4, Equity Compensation, Rule 10b5-1